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Background: Diabetes is a common and very prevalent disease affecting the citizens of both developed and 
developing countries. Many oral hypoglycaemic agents available for the treatment have significant side effects and 
sometimes are found to be ineffective in chronic diabetic patients.  
Objective: To study the acute toxicity and effect of the ethanol stem-bark extract of Annona senegalensis on blood 
glucose in alloxan-induced diabetic rats. 
Material and Methods: Hypoglycaemic effect of the extract was studied in normal rats using oral glucose tolerance 
test and in alloxan-induced diabetic rats. Effects of 100, 200 and 300 mg/kg, i.p of ethanol stem-bark extract of Annona 
senegalensis, and glibenclamide (5 mg/kg, i.p) were studied on blood glucose. 
Results: The median lethal dose of the extract was found to be 1131.4 mg/kg by intraperitoneal route. In the normal 
rats (OGTT), from basal to 0 min, the extract did not show significant reduction in the fasting serum glucose level. 
However, the extract at 300 mg/kg and glibenclamide (5 mg/kg) significantly (p≤ 0.05) prevented glucose induced 
hyperglycemia at 30 to 90 min as compared to normal control. In the alloxan-induced diabetic rats, 100, 200 and 300 
mg/kg of the extract produced significant (p≤0.05) reduction in blood glucose levels. Maximum effect was observed 
with the 300 mg/kg dose of stem-bark of Annona senegalensis.  
Conclusion: The results showed that the ethanol extract of the stem bark of the plant possessed antihyperglycaemic 
activity. 
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1. Introduction 
Diabetes is a chronic disorder in metabolism of 
carbohydrates, proteins, and fat due to absolute or 
relative deficiency of insulin secretion with or without 
varying degree of insulin resistance. (Barar, 2000). It 
may also be defined as a disease where the body either 
produces little insulin or ceases to produce insulin, or 
becomes progressively resistant to its action (Ran and 
Ramanu, 2002). Diabetes is a common and very 
prevalent disease affecting the citizens of both 
developed and developing countries (Erasto et al, 
2005). It is ranked seventh among the leading causes of 
death, and third when all its fatal complications are 
taken into account, because of its high prevalence, 
morbidity and mortality (Trivedi et al, 2004).  The 
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number of individuals suffering from diabetes in Nigeria 
for instance is expected to increase from 3, 746, 5000 in 
2014 (IDF 2014) to 4, 835, 000 by 2030 (WHO, 2010). 
Many oral hypoglycaemic agents, such as biguanides 
and sulfonylureas are available along with insulin for 
the treatment of diabetes mellitus, but they have 
significant side effects and sometimes they are found to 
be ineffective in chronic diabetic patients (Defronzo and 
Goodman 1995; Nathan et al, 2006). Thus, there is an 
increasing demand of natural and synthetic products 
with high antidiabetic potential and lesser side effects. 
The research conducted over the last several decades 
has shown that plant and plant-based therapies have 
high potential to treat and control diabetes and its 
complications (Singh et al, 2008). Diabetes has been 
treated orally with several medicinal plants or their 
extracts, based on folklore medicine. Therefore, search 
for safe and more effective agents has continued to be 
an important area of active research.  
Annona senegalensis Pers. (Annonaceae) commonly 
known as “wild custard apple” is widely grown in 
Nigeria where it is commonly known as “Gwandar daaji” 
in Hausa, and “abo emeaso” in Yoruba (Alawa et al, 
2003; Sulaiman et al, 2008). The plant grown as a shrub 
or small tree, has aromatic flowers which are used to 
flavour food. The ripe fruit is yellow in colours and has a 
sweet edible jelly with pleasant odour. 
The biological activities of the plant extract reported by 
many researches justified the use of the plant in 
traditional medicine. For instance, the plant extracts 
were found to possess antimalarial, antidiarrhoea, 
antibacterial and anthelmintic properties (Alawa et al, 
2003; Ajaiyeoba et al, 2006). The plant decoction is used 
in the treatment of sleeping sickness in northern 
Nigeria (Igwe and Onabanjo, 1989) and in folkloric 
treatment of cancer (Graham et al, 2000; Abubakar et al, 
2007).  It is used in chest pain, coughs, anaemia, urinary 
tract infections (Muanza et al, 1994) as well as  
intestinal troubles and stomach ache (Dalziel, 1955), 
diarrhea, body stool, dysentry (Muanza et al, 1994; 
Ekpendu et al, 1998) and veneral disease (Durodola, 
1975). The plant has also been shown to be beneficial in 
the treatment of snake bite (Adzu et al, 2005).  
In the light of the above data, the objectives of the 
present study were to evaluate (1) the acute toxicity of 
the stem bark extracts of A. senegalensis and (2) effect 
the extracts on blood glucose in normal as well as  
alloxan-induced diabetic rats. 
2. Materials and Methods 
2.1 Plant Collection 
The stem bark of the plant, Annona senegalensis was 
collected Yako in Kiru Local Government Area of Kano 
State.  The plant specimen was identified by Mal. Baba 
Ali Garko and authenticated by Prof. Bala Sidi of 
Biological Sciences Department, Bayero University, 
Kano where a voucher number (BUKHAN0029) was 
assigned for reference. 
2.2 Chemicals 
All chemicals and drugs were obtained commercially 
and were of analytical grade. Alloxan monohydrate 
(Sigma Aldrich, St. Louis, MO, USA) Glibenclamide 
(NAFDAC Reg. No 04-1601). 
2.3 Experimental Animals 
Adult Wistar rats (200-250 g) of either sex were 
obtained from Department of Pharmacology, Faculty of 
Medicine, Bayero University, Kano and used for the 
study.  The animals were kept in standard cages in the 
departmental animal house for two weeks to 
acclimatize. Animals were fed with commercial feed 
(vital feed) and water was given ad libitum. Animals 
described as fasted were deprived of food for 18 h but 
had free access to water. 
2.4 Extraction 
The plant material was dried under shade and then 
pulverized into powder. The powder was percolated 
with 96% v\v ethanol for two weeks. The ethanol 
extract was filtered and concentrated using rotary 
evaporator at 40°C. The crude extract obtained was 
kept in deep freezer until use. 
2.5 Phytochemical screening 
The preliminary phytochemical screening of the crude 
ethanol stem bark extract of A. senegalensis was carried 
out in order to ascertain the presence of alkaloids, 
saponins, steroids, flavonoids and reducing sugar using 
protocols described in Trease and Evans (1983). 
2.6 Acute toxicity study 
The median lethal dose (LD50) of the ethanol stem bark 
extract of A. senegalensis was determined by method of 
Lorke (1983). In the initial phase 9 rats were divided 
into 3 groups of 3 rats each and treated with the extract 
at doses of 10, 100 and 1000 mg/kg body weight 
intraperitoneally (i.p) and observed for 24 hours for 
signs of toxicity or death. In the second phase, another 4 
rats were divided into 4 groups of 1 rat each and were 
administered with the extract at the doses of 200, 400, 
800 and 1600 mg/kg body weight respectively (i.p). The 
animals were all kept under same conditions and 
mortality was recorded in each group within 24 h.  
2.7 Oral Glucose Tolerance Test (OGTT) 
Oral Glucose Tolerance Test (OGTT) in normal rats was 
performed by dividing fasted rats into groups of five. 
Group I served as normal control and received distilled 
water. Group 2, 3 and 4 received the 100 mg/kg, 200 
mg/kg and 300 mg/kg of the extract as an aqueous 
suspension respectively. Group 5 received the reference 
drug Glibenclamide 5 mg/kg. The serum glucose level 
for all the groups were estimated prior to the 
administration of the extract and reference drug and 
were considered as basal readings. Immediately after 
blood withdrawal, all the experimental groups were 
administered with respective doses of the extract and 
reference drug.  
After 30 minutes of administrations, the serum glucose 
level of all groups was recorded to evaluate the 
hypoglycaemic effect of extract and reference drug in 
normal rats and these readings were considered as the 
readings at 0 min. Glucose (2 g/kg) was loaded in all the 
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groups at 0 min and blood samples were collected from 
the rat tail vein at 30, 60, 90 and 120 minutes after 
glucose loading. Blood glucose levels were measured 
using ACCU-CHEK (active) glucometer. 
2.8 Alloxan Induced hyperglycaemia 
The rats were fasted for 12 hours before the 
commencement of the experiment, but were allowed to 
take water ad libitum. Their fasting blood glucose was 
taken before being treated with alloxan. Diabetes was 
then induced by a single i.p. of alloxan monohydrate at a 
dose of 150 mg/kg body weight to each rat. The rats 
were kept for the next 24h on 5% glucose solution to 
prevent hypoglycaemia. The diabetic state was assessed 
by measuring the blood glucose levels after 72h. The 
rats with blood glucose levels above 199 mg/dl were 
considered diabetic and included in the study. Blood 
samples were obtained from the tail end of each rat. The 
blood glucose estimations were made using ACCU-CHEK 
(active) glucometer, Johnson Company, USA.  
Rats with blood glucose level between 200 and 400 
mg/dl were selected and divided into five groups each 
containing five rats as follows: 
Group 1, served as untreated diabetic control. 
Group 2, served as diabetic-treated with 100 mg/kg 
extract. 
Group 3, served as diabetic-treated with 200 mg/kg 
extract. 
Group 4, served as diabetic-treated with 300 mg/kg 
extract. 
Group 5, served as diabetic-treated with 5 mg/kg 
glibenclamide (standard control). 
Blood samples were collected by cutting the tail-tip of 
the rats, for blood glucose determination at intervals of 
0, 2, 4, 8, 16 and 24 hours using ACCU-CHEK (active) 
glucometer, Johnson Company, USA instrument. 
2.9 Statistical analysis 
The data were expressed as mean ± SEM. Statistical 
analysis was performed using Microsoft Excel 2010 
Analysis ToolPak. The effect of the extract was 
evaluated for each group in the alloxan–induced 
diabetic model by calculating the percentage glycaemic 
change using following formula:  
% Glycaemic change = (Gi – Gt) x 100 
      Gi 
Where: 
Gi = the value of initial glucose concentration (0 min 
in OGTT and alloxan-induced diabetes model)  
Gt = glucose concentration at different intervals.  
Positive (+) indicates decrease and negative (-) signifies 
increase. The treatments and control groups were 
compared using paired Student’s t-test, values of p≤0.05 
were considered statistically significant.   
 
3. Results  
Phytochemical investigation of the freshly prepared 
extract revealed the presence of alkaloid, saponins and 
flavonoids as secondary metabolites. Steroids and 
reducing sugars were absent.  
The intraperitoneal median lethal dose (LD50) of the 
ethanol stem back extract of the A. senegalensis in rats 
was calculated to be 1131.4 mg/kg body weight using 
Lorke (1983) Method (Table 1).  Other signs of toxicity 
were observed from 600 mg/kg and include decrease in 
locomotor activity, piloerection and sensitivity to touch 
as well as feed intake. The severity of the signs 
increased with increasing dose. 
      Table 1: Mortality of Ethanol Stem Bark Extract of Anona senegalensis in Wistar Rats 
Initial Phase  Second Phase 
Dose (mg/kg) Mortality  Dose (mg/kg) Mortality 
10 0/3  200 0/1 
100 0/3  400 0/1 
1000 2/3  800 0/1 
   1600 1/1 
Mortality is expressed as number of animal which died/number of animal(s) used. 
Oral glucose tolerance test  
The serum glucose level, after oral administration of 
glucose in normal control and treated rats are given in 
Table 2. Neither the reference drug (glibenclamide) nor 
the extract showed any hypoglycaemic effect in normal 
rats as evident by basal to 0 min. readings. Thirty (30) 
minutes after glucose administration the blood glucose 
level increased rapidly from the fasting value and peak 
60 min, then subsequently decreased. As expected, 
glibenclamide (5 mg/kg) was observed to prevented 
glucose induced hyperglycemia significantly at 30 to 90 
min (p≤ 0.05) as compare to normal control. The extract 
(200 and 300 mg/kg) at 60 to 90 min also significantly 
(p≤ 0.05) prevented the hyperglycaemia. Maximum 
glucose tolerance in Annona senegalensis extracts was 
observed with 300 mg/kg in 90 minutes compared with 
the normal control. 
Alloxan Induced hyperglycaemia 
Evaluating the effect of the extract on blood glucose 
levels of alloxan-induced diabetic rats showed that, the 
extract improved the percentage glycaemic change by 
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lowering the blood glucose level (10-19%) in dose 
dependent manner within the first 2 hours of the 
extract administration. The single dose (300 mg/kg) of 
the ethanol extract of Annona senegalensis showed 
significant reduction (p≤0.05) at two hours that was 
comparable to that the reference drug. Further 
significant (P<0.005) decrease (28-33%) was observed 
after 4 hours of the extract administration at 200 and 
300 mg/kg when compared to the control. The 
significant decrease was sustained up to 16 hours post 
administration by 300 mg/kg of the extract. Though 
100 and 200 mg/kg body weight of the extract also 
sustained the blood glucose levels lowering 8 to 16 
hours after administration, the percentage glycaemic 
change was not statistically significant.  Maximum blood 
glucose level lowering effect (40%) was observed with 
300 mg/kg 8 hours after administration of the extract 
when compared to diabetic control (Table 3). No 
significant improvements in percentage glycaemic 
change were recorded with all the three doses of the 
extract after the 24th hour.  
As expected, negative percentage glycaemic change 
(increase in blood glucose level) was observed from 4 
up to 24th hour after administration of normal saline in 
the control group. In contrast, the reference drug (5 
mg/kg glibenclamide) was found to non-significantly 
lower the blood glucose level at 8th hour after 
administration and significantly improved the 
percentage glycaemic change  at 4th hour (p 0.05) and 
between 16 and 24th hour (p 0.005) when compared to 
diabetic control rats. 
 
Table 2: Effect of the Ethanol Stem Bark Extract of Anona senegalensis on Serum Glucose Levels on Glucose Loaded 
Normal Rats (OGTT study) 
Dose 
Serum glucose level (mg/dl) 
Basal 0 min 30 min 60 min 90 min 120 min 
N/S 10ml/kg 93.17 ± 0.83 91.83 ± 1.01 133.33 ± 1.91 157.67 ± 2.30 125.33 ± 1.38 94.20 ± 1.16 
Extract 
(100mg/kg) 
93.50 ± 1.43 91.67 ± 0.80 ns 132.67 ± 0.99 ns 152.33 ± 1.82 ns 124.83 ± 1.11 ns 94.67 ± 0.84 ns 
Extract 
(200mg/kg) 
91.50 ± 1.59 90.83 ± 1.10 ns 131.67 ± 1.13 ns 147.67 ± 0.67 a 119.83 ± 1.45 a 89.67 ± 2.91 ns 
Extract 
(300mg/kg) 
92.83 ± 1.28 92.17 ± 1.30 ns 130.00 ± 0.97 ns 145.50 ± 1.41 a 118.17 ± 1.66b 89.17 ± 2.98 ns 
Glibenclamide 
(5mg/kg) 
91.73 ± 1.39 91.17 ± 1.54 ns 127.83 ± 1.49a 143.83 ± 1.56 b 118.00 ± 1.65 b 91.67 ± 1.54 ns 
Key:  ns = Not significant; a =P<0.05; b = P<0.005 compared to control (N/S) using One way Anova followed by Dunnett’s post hoc 
test 
 
Table 3: Effects of Ethanol Stem Bark Extract of Annona senegalensis on Induced Diabetic Wistar Albino Rats 
Group 
% Glycemic Change (mean ± SEM) 
0 hr 2 hr 4 hr 8 hr 16 hr 24 hr 
N/S 10ml/kg 0 ± 0.00  0.31 ± 3.95   -7.41 ± 2.00  - 11.23  ± 6.24  - 20.35 ± 9.48  -31.67 ± 8.66  
Extract (100mg/kg) 0 ± 0.00 10.66 ± 9.51ns  16.60 ± 8.51a  6.36 ± 10.29ns 4.28 ± 14.98ns  2.48 ± 3.29ns 
Extract (200mg/kg) 0 ± 0.00  10.97 ± 6.87ns  27.85 ± 5.35b  21.75 ± 24.74ns  3.61 ± 24.51ns 3.53 ± 17.58ns 
Extract (300mg/kg) 0 ± 0.00 18.99 ± 7.46a  24.68 ± 5.20b   40.21 ± 10.27a  32.73 ± 9.72b  8.09 ± 5.07ns 
Glibenclamide (5mg/kg) 0 ± 0.00 17.26 ± 1.24a 20.68 ± 17.98a 22.87 ± 10.39ns 28.15  ± 2.86b 19.17  ± 0.83b 
Key: ns = Not significant; a =P<0.05; b = P<0.005 compared to control (N/S) using One way Anova followed by Dunnett’s post hoc 
test  
Positive (+) percentage glycaemic change indicates decrease and negative (-) percentage glycaemic change signifies increase. 
Calculated as described in text 
 
4.0 Discussion 
Phytochemical investigation of the freshly prepared 
extract revealed the presence of alkaloid, saponins and 
flavonoids as secondary metabolites. Similar result was 
obtained on root bark extract of the plant by Okoye et 
al, (2012). Many of these compounds have been shown 
to produce potent hypoglycaemic, antihyperglycaemic, 
and glucose suppressive activities (Tanko et al, 2008). 
These effects might be achieved by facilitating insulin 
release from beta pancreatic cells, inhibiting glucose 
absorption in gut, stimulating glycogenesis in liver 
and/or increasing glucose utilization by the body.  
In acute toxicity study, decrease in locomotor activity 
and sensitivity to touch as well as decreased feed intake 
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were observed 8–12 hours after administration of the 
extract in the second phase. The median lethal dose 
(LD50) of the ethanol stem back extract of the A. 
senegalensis in rats was calculated to be 1131.4 mg/kg 
body weight. The LD50 obtained suggests that the 
ethanol stem bark extract of A. senegalensis may be less 
toxic with some risk of acute intoxication at high doses 
in rats.     
Pancreas is the primary organ involved in sensing the 
organism’s dietary and energetic states via glucose 
concentration in the blood and in response to elevated 
blood glucose insulin is secreted (Edem, 2009). 
Although the precise mechanism of alloxan-induced 
diabetes remains unclear, there is increasing evidence 
that alloxan preferentially accumulate in pancreatic β- 
cells via the GLUT2 glucose transporter. In the presence 
of intracellular thiols, especially glutathione, alloxan 
generates reactive oxygen species (ROS) in a cyclic 
redox reaction with its reduction product, dialuric acid. 
Autoxidation of dialuric acid generates superoxide 
radicals, hydrogen peroxide and, in a final iron-
catalysed reaction step, hydroxyl radicals. These 
hydroxyl radicals are ultimately responsible for the 
death of the β-cells, which have a particularly low 
antioxidative defence capacity, and the ensuing an 
insufficient release of insulin (Lenzen 2008) from the β-
cells of the islets of Langerhans. An insufficient release 
of insulin, leads to high blood glucose level or 
hyperglycemia (Grover et al, 2002). Insulin deficiency 
leads to various metabolic alterations in the animals, 
viz. increased blood glucose, increased cholesterol and 
transaminases (Shanmugasundaram et al, 1983). The 
fundamental mechanism underlying hyperglycemia in 
diabetes mellitus involves overproduction (excessive 
hepatic glycogenolysis and gluconeogenesis) and 
decreased utilization of glucose by the tissues (Jayasri et 
al, 2008).  
In the present study the antihyperglycaemic activity of 
ethanol stem bark extract of Annona senegalensis was 
evaluated in normal (OGTT) and in alloxan induced 
diabetic rats, respectively. Notable antihyperglycaemic 
activity was observed with the Annona senegalensis 
crude extracts both in the normal (OGTT) and in alloxan 
induced diabetic rats. Annona senegalensis, being an 
antioxidant (Ajboye et al, 2010) may prevent damage to 
the pancreatic islet cell induced by the cytotoxic oxygen 
radicals (Bhattacharya, 1995). Another reason for the 
plasma glucose lowering action may be due to the 
decreased gluconeogenesis, which appears to be related 
to the antioxidant properties of the plant extract (Ortiz-
Andrade et al, 2007). The antihyperglycaemic effect 
may also be due to the presence of insulin-like 
substance found in various plants (Gray and Flatt 1999). 
The reference drug (5 mg/kg glibenclamide) was found 
to significantly improve the percentage glycaemic 
change between 16 and 24th hour, which could be 
explained by longer half-life of glibenclamide (2-24h).  
5.0 Conclusion  
The findings of this study indicate the presence of 
various phytochemicals in the plant extracts, which may 
be responsible for the pharmacological activity. The 
extract significantly decreased the blood glucose levels 
in dose dependent manner. The extract at 300 mg/kg 
appear to have comparative effect with glibenclamide 5 
mg/kg. Further studies is recommended that may lead 
to possible isolation of active molecule and evaluating 
its safety profile. 
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